Judge Karen Marston issued a July 2 case management order directing early discovery in the Ozempic and Wegovy NAION litigation to focus first on cross-cutting issues: whether plaintiffs can establish general causation between GLP-1 drugs and vision loss, and whether federal law preempts failure-to-warn claims
Autophagy inhibition may sensitize pancreatic cancer to radiotherapy, as radiation was shown to induce autophagy (246)
These distinctions matter when interpreting online comparisons or social media claims
Compounded semaglutide is not Ozempic or Wegovy, and compounded tirzepatide is not Mounjaro or Zepbound
[DOI] [PMC free article] [PubMed] [Google Scholar] 3.Dirksen C, Jrgensen NB, Bojsen-Mller KN, Kielgast U, Jacobsen SH, Clausen TR, Worm D, Hartmann B, Rehfeld JF, Damgaard M, Madsen JL, Madsbad S, Holst JJ & Hansen DL
Until those results are published, we must rely on what we know from the broader GLP-1 medication class and the biology of weight-loss-related hair shedding
